A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coronary Stent System in Japanese Population

NACompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

December 31, 2013

Conditions
Vascular DiseaseMyocardial IschemiaCoronary Artery StenosisCoronary DiseaseCoronary Artery DiseaseCoronary Restenosis
Interventions
DEVICE

XIENCE PRIME SV EECSS

Patients receiving XIENCE PRIME SV EECSS

Trial Locations (14)

Unknown

Kokura Memorial Hospital, Kitakyushu

Hokkaido Social Insurance Hospital Cardiovascular Center, Toyohira

Teikyo University, Tokyo

Tokai University Hospital, Isehara

Shonan Kamakura General Hospital, Kamakura

Saiseikai Yokohama City Eastern Hospital, Yokohama

Kumamoto Central Hospital, Kumamoto

Kyoto University Hospital, Sakyo-ku

Sendai Kousei Hospital, Sendai

Nagoya Daini Red Cross Hospital, Shōwaku

Kurashiki Central Hospital, Kurashiki

Sakurabashi Watanabe Hospital, Kita-ku

Osaka University Hospital, Suita

Tokushima Red Cross Hospital, Komatsushimachō

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY